Hemolytic uremic syndrome following Campath-1H induction

被引:7
作者
Bonatti, Hugo
Brandacher, Gerald
Boesmueller, Claudia
Cont, Micol
Hengster, Paul
Rosenkranz, Alexander R.
Krugmann, Jens
Margreiter, Raimund
机构
[1] Univ Innsbruck, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Div Nephrol, Dept Internal Med, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Inst Pathol, Innsbruck, Austria
关键词
renal transplantation; Campath-1H; haemolytic uremic syndrome; Rapamycin;
D O I
10.1111/j.1432-2277.2006.00445.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hemolytic uremic syndrome (HUS) is a rare complication following solid organ transplantation. We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin. However, graft function could not be restored.
引用
收藏
页码:386 / 389
页数:4
相关论文
共 22 条
  • [1] Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus
    Abraham, KA
    Little, MA
    Dorman, AM
    Walshe, JJ
    [J]. TRANSPLANT INTERNATIONAL, 2000, 13 (06) : 443 - 447
  • [2] Blackall Douglas P, 2004, Am J Clin Pathol, V121 Suppl, pS81
  • [3] Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients
    Calne, R
    Friend, P
    Moffatt, S
    Bradley, A
    Hale, G
    Firth, J
    Bradley, J
    Smith, K
    Waldmann, H
    [J]. LANCET, 1998, 351 (9117) : 1701 - 1702
  • [4] Attempted treatment of factor H deficiency by liver transplantation
    Cheong, HI
    Lee, BS
    Kang, HG
    Hahn, H
    Suh, KS
    Ha, IS
    Choi, Y
    [J]. PEDIATRIC NEPHROLOGY, 2004, 19 (04) : 454 - 458
  • [5] The use of campath-1H as induction therapy in renal transplantation: Preliminary results
    Ciancio, G
    Burke, GW
    Gaynor, JJ
    Mattiazzi, A
    Roohipour, R
    Carreno, MR
    Roth, D
    Ruiz, P
    Kupin, W
    Rosen, A
    Esquenazi, V
    Tzakis, AG
    Miller, J
    [J]. TRANSPLANTATION, 2004, 78 (03) : 426 - 433
  • [6] De novo hemolytic-uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: Role of sirolimus
    Franco, A
    Hernandez, D
    Capdevilla, L
    Errasti, P
    Gonzalez, M
    Ruiz, JC
    Sanchez, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1764 - 1766
  • [7] Franz M, 1998, TRANSPLANTATION, V66, P1258
  • [8] Gatti S, 2003, J NEPHROL, V16, P586
  • [9] Hemolytic uremic syndrome in small-bowel transplant recipients: the first two case reports
    Humar, A
    Jessurun, J
    Sharp, HL
    Gruessner, RWG
    [J]. TRANSPLANT INTERNATIONAL, 1999, 12 (05) : 387 - 390
  • [10] Isaacs JD, 1996, BRIT J RHEUMATOL, V35, P231